Recognizing, defining, and managing CAR-T hematologic toxicities.
Rejeski K, Subklewe M, Locke FL.
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):198-208. doi: 10.1182/hematology.2023000472.
Dengue-associated hemophagocytic lymphohistiocytosis in an adult: A case report and literature review.
Chung SM, Song JY, Kim W, Choi MJ, Jeon JH, Kang S, Jung E, Noh JY, Cheong HJ, Kim WJ.
Medicine (Baltimore). 2017 Feb;96(8):e6159. doi: 10.1097/MD.0000000000006159.
Hemophagocytic lymphohistiocytosis in Egyptian children: diagnosis, treatment challenges, and outcome.
Tantawy AA, Elsherif NHK, Elsayed SM, Ali HGA, Makkeyah SM, Elsantiel HIE, de Saint Basile G, Ragab IA.
Expert Rev Hematol. 2024 Apr-May;17(4-5):153-163. doi: 10.1080/17474086.2024.2341044. Epub 2024 Apr 15.
Risk factors for mixed chimerism in children with hemophagocytic lymphohistiocytosis after reduced toxicity conditioning.
Wustrau K, Greil J, Sykora KW, Albert MH, Burkhardt B, Lang P, Meisel R, Wössmann W, Beier R, Schulz A, Bader P, Chada M, Kühl JS, Schlegel PG, Speckmann C, Gruhn B, Seidel M, Wawer A, Ozga AK, Janka G, Ehl S, Müller I, Lehmberg K.
Pediatr Blood Cancer. 2020 Sep;67(9):e28523. doi: 10.1002/pbc.28523. Epub 2020 Jul 3.
Generation and characterization of four Chediak-Higashi Syndrome (CHS) induced pluripotent stem cell (iPSC) lines.
Serra-Vinardell J, Sandler MB, Pak E, Zheng W, Dutra A, Introne W, Gahl WA, Malicdan MC.
Stem Cell Res. 2020 Jun 22;47:101883. doi: 10.1016/j.scr.2020.101883. Online ahead of print.
Chimeric antigen receptor T-cells safety: A pharmacovigilance and meta-analysis study.
Dolladille C, Ederhy S, Ezine E, Choquet S, Nguyen LS, Alexandre J, Moslehi JJ, Dechartres A, Salem JE.
Am J Hematol. 2021 Sep 1;96(9):1101-1111. doi: 10.1002/ajh.26259. Epub 2021 Jun 23.
Macrophage activation syndrome associated with systemic lupus erythematosus treated successfully with the combination of steroid pulse, immunoglobulin and tacrolimus.
Aoyama-Maeda N, Horino T, Ichii O, Terada Y.
Rom J Intern Med. 2018 Jun 1;56(2):117-121. doi: 10.1515/rjim-2017-0043.
Hemophagocytic Syndrome Associated with Mycoplasma pneumoniae Pneumonia.
Koike Y, Aoki N.
Case Rep Pediatr. 2013;2013:586705. doi: 10.1155/2013/586705. Epub 2013 Jul 18.
COVID-19: High-JAKing of the Inflammatory "Flight" by Ruxolitinib to Avoid the Cytokine Storm.
Botta C, Indrieri A, Garofalo E, Biamonte F, Bruni A, Pasqua P, Cesario F, Costanzo FS, Longhini F, Mendicino F.
Front Oncol. 2021 Jan 8;10:599502. doi: 10.3389/fonc.2020.599502. eCollection 2020.
